Quest Diagnostics DGX Apple Health Partnership Tests Valuation

Quest Diagnostics (DGX) is gaining attention after announcing an integration with Apple Health that allows iPhone and iPad users to order a $119 preventive lab panel checking over 50 biomarkers.

The move comes as Quest Diagnostics' share price has risen 12.98% in the past 90 days and 34.07% year-to-date, with a strong multi-year run.

However, investors are questioning whether the current valuation justifies the balance between reimbursement risk and new consumer demand.